Industry veterans Paul Peter Tak and Eric Meldrum join Citryll’s Board
AVC-Boosters are designed as dual agonistic antibodies to safely deliver targeted and potentmonotherapy with broad application...
Stay informed about the latest updates from Curie Capital and the ongoing activities within our portfolio companies.
AVC-Boosters are designed as dual agonistic antibodies to safely deliver targeted and potentmonotherapy with broad application...
Cincinnati, Ohio, US and Eindhoven, Netherlands – February 27, 2025 - Sirius Medical, the innovator of Surgical Marker...
Eindhoven, the Netherlands – 4 February 2025 – As World Cancer Day is observed, Dutch medical device company Sirius...
TGD001 is being developed to offer patients with clotting disorders a faster, safer and more effective treatment than today’s...
Financing co-led by Johnson & Johnson Innovation – JJDC, Inc., Forbion and Novartis Venture Fund Lead first-in-class product...
Amsterdam, Netherlands – 13 August 2024 – Pitchbook has recently awarded Curie Capital with a 5th place among Dutch Venture...